David Charles Lubner, SVP and CFO at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 15,000 shares at $39.28 ($589K) on 2015-05-14, disclosed to the SEC on 2015-05-18.
Scheduled sale ($589k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.28 | 7,316 | $287K | 48.8% |
| 2 | $39.28 | 7,684 | $302K | 51.2% |
| Total | $39.28 avg | 15,000 | $589K | 100% |
| Filing → |
| PNT | BUY | 2022-11-28 | $25K | — | Filing → |
| TTPH | SELL | 2015-08-17 | $408K | — | Filing → |
| TTPH | SELL | 2015-07-15 | $367K | — | Filing → |